glp 1 receptor agonists beyond their pancreatic effects The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases Risk of pancreatic cancer associated
Description
Circulating levels of Gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials
Headache 2017;57:1303-10
Some studies have shown greater average weight loss with tirzepatide compared with semaglutide, but the best choice depends on the patients medical history, treatment goals, side-effect tolerance, metabolic risk, and physician evaluation
Funding The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article
